2 recruiting, 1 completed. 2 Phase 4, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Placebo intramuscular injection: new trials by email Literature Review of Placebo intramuscular injection trials Research Report on Placebo intramuscular injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Interleukin-2 for Refractory Chronic Spontaneous Urticaria Placebo intramuscular injection, Human interleukin-2 (I) intramuscular injection - Chronic Spontaneous Uriticaria | Phase 2 / Phase 3 | Recruiting | Second Xiangya Hospital of Central South University | 124 | 2025-03-19 | 2025-04-11 |
| Naltrexone in AUD Reward Drinkers XR-NTX 380 mg, intramuscular injection, Medical Management, Placebo intramuscular injection - Alcohol Use Disorder, Alcoholism | Phase 4 | Recruiting | University of Pennsylvania | 60 | 2022-03-07 | 2026-01-20 |
| Mesoglycan, Vascular Reactivity and Metabolic Syndrome Flow Mediated Dilation, Mesoglycan, Placebo - Metabolic Syndrome | Phase 4 | Completed | Federico II University | 30 | 2013-05-01 | 2014-10-02 |
Alcoholism (1) · Metabolic Syndrome (1)
Federico II University (1) · Second Xiangya Hospital of Central South University (1) · University of Pennsylvania (1)
China (1) · Italy (1) · United States (1)
Hai Long, MD, PhD (1) · Henry R Kranzler, MD (1) · Qianjin Lu, MD, PhD (1) · Ugo Oliviero, MD (1)